Indian Pharmacopoeia Commission (IPC) issued a drug safety alert for painkiller ‘Meftal’. Here are some pointers that parents should know to treat fever in kids | Health
Blue Cross Laboratories, the owner of the Meftal painkiller brand, has clarified that the adverse reaction the Indian Pharmacopoeia Commission (IPC) has flagged is a rare event. The company claims that the product s constituent, mefenamic acid, can cause adverse reactions, including eosinophilia and systemic symptoms (DRESS) syndrome.
Govt alerts on common painkiller Meftal: Other banned drugs we are using indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
The Indian Pharmacopoeia Commission s advisory alerts users about Meftal s dangers, specifically its active ingredient mefenamic acid, linked to severe allergic reactions like DRESS syndrome. This syndrome, a type 4 hypersensitivity reaction, causes skin issues, fever, and organ abnormalities. Meftal s risks extend to stomach ulcers, bleeding, and kidney problems with prolonged use. Users are urged to consult doctors, avoid self-medication, and prioritize safety, emphasizing informed decision-making when considering this widely used painkiller.